AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Entera Bio Ltd. Director's Dealing 2022

Jul 25, 2022

35604_dirs_2022-07-25_f62eb585-16b0-40d2-82ed-c0b6aec01063.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2022-01-18

Reporting Person: Ellis Sean (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares, par value NIS 0.0000769 per share	17200	Direct

Footnotes

F1: This Form 4 amendment is being filed to correct the original Form 4 filed on January 19, 2022. The original Form 4 inadvertently omitted 7,200 ordinary shares held directly by the Reporting Person.